Latest news

Thumbnail image for Roche to file entrectinib for ROS-1 positive NSCLC

Roche to file entrectinib for ROS-1 positive NSCLC

Roche is planning to file its investigational cancer drug entrectinib following positive results from early and mid-stage trials with patients with ROS1-positive non-small cell lung cancer (NSCLC).

26th September 2018

Thumbnail image for US clears Verastem’s Copiktra for blood cancers

US clears Verastem’s Copiktra for blood cancers

Verastem Oncology’s Copiktra has been approved in the US for the treatment relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma after at least two prior therapies.

25th September 2018

Thumbnail image for Keapstone satisfies conditions for further £1m investment

Keapstone satisfies conditions for further £1m investment

Virtual biotech Keapstone Therapeutics is in line for a further £1 million investment from Parkinson’s UK to move forward its innovative disease-modifying therapeutic approach to motor neuron disease (MND) and Parkinson’s.

25th September 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download